APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Peptide CDMO Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Custom Peptide CDMO Services Industry Growth and Trends Forecast to 2032

2 May 2026110 pages

Choose your research edition.

Industry ResearchCustom Peptide CDMO Services Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Peptide CDMO Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Custom Peptide CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Peptide CDMO Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Peptide CDMO Services Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

According to APO Research, the global Custom Peptide CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Custom Peptide CDMO Services market include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Custom Peptide CDMO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Custom Peptide CDMO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Custom Peptide CDMO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Custom Peptide CDMO Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Custom Peptide CDMO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Custom Peptide CDMO Services Market by Company

Bachem

CordenPharma

PolyPeptide

AmbioPharm

Genscript

Thermo Fisher

USV Peptides

Bio Basic

ScinoPharm

JPT

CBL

Piramal Pharma

CPC Scientific

Creative Peptides

Chinese Peptide Company

ChengDu ShengNuo Biotec

AppTec Co., Ltd.

GL Biochem

Custom Peptide CDMO Services Segment by Type

GMP Services

Non-GMP Services

Custom Peptide CDMO Services Segment by Application

Commercial

Scientific Research

Other

Custom Peptide CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Peptide CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Peptide CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Peptide CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Custom Peptide CDMO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Custom Peptide CDMO Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Custom Peptide CDMO Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Custom Peptide CDMO Services Market Share by Region (2021-2026) Table 4. Global Custom Peptide CDMO Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Custom Peptide CDMO Services Market Share by Region (2027-2032) Table 6. Global Custom Peptide CDMO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Custom Peptide CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Custom Peptide CDMO Services Market Size Share by Type (2021-2026) Table 9. Global Custom Peptide CDMO Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Custom Peptide CDMO Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Custom Peptide CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Custom Peptide CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Custom Peptide CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Custom Peptide CDMO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Custom Peptide CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Custom Peptide CDMO Services Market Size Share by Application (2021-2026) Table 24. Global Custom Peptide CDMO Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Custom Peptide CDMO Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Custom Peptide CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Custom Peptide CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Custom Peptide CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Custom Peptide CDMO Services Industry Trends Table 37. Custom Peptide CDMO Services Industry Drivers Table 38. Custom Peptide CDMO Services Industry Opportunities and Challenges Table 39. Custom Peptide CDMO Services Industry Restraints Table 40. Global Custom Peptide CDMO Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Custom Peptide CDMO Services Revenue Market Share by Company (2021-2026) Table 42. Global Custom Peptide CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Custom Peptide CDMO Services Key Company Headquarters & Area Served Table 44. Global Custom Peptide CDMO Services Company, Product Type & Application Table 45. Global Custom Peptide CDMO Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Custom Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Bachem Company Information Table 49. Bachem Business Overview Table 50. Bachem Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Bachem Custom Peptide CDMO Services Product Portfolio Table 52. Bachem Recent Development Table 53. CordenPharma Company Information Table 54. CordenPharma Business Overview Table 55. CordenPharma Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CordenPharma Custom Peptide CDMO Services Product Portfolio Table 57. CordenPharma Recent Development Table 58. PolyPeptide Company Information Table 59. PolyPeptide Business Overview Table 60. PolyPeptide Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. PolyPeptide Custom Peptide CDMO Services Product Portfolio Table 62. PolyPeptide Recent Development Table 63. AmbioPharm Company Information Table 64. AmbioPharm Business Overview Table 65. AmbioPharm Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AmbioPharm Custom Peptide CDMO Services Product Portfolio Table 67. AmbioPharm Recent Development Table 68. Genscript Company Information Table 69. Genscript Business Overview Table 70. Genscript Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Genscript Custom Peptide CDMO Services Product Portfolio Table 72. Genscript Recent Development Table 73. Thermo Fisher Company Information Table 74. Thermo Fisher Business Overview Table 75. Thermo Fisher Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Thermo Fisher Custom Peptide CDMO Services Product Portfolio Table 77. Thermo Fisher Recent Development Table 78. USV Peptides Company Information Table 79. USV Peptides Business Overview Table 80. USV Peptides Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. USV Peptides Custom Peptide CDMO Services Product Portfolio Table 82. USV Peptides Recent Development Table 83. Bio Basic Company Information Table 84. Bio Basic Business Overview Table 85. Bio Basic Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bio Basic Custom Peptide CDMO Services Product Portfolio Table 87. Bio Basic Recent Development Table 88. ScinoPharm Company Information Table 89. ScinoPharm Business Overview Table 90. ScinoPharm Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ScinoPharm Custom Peptide CDMO Services Product Portfolio Table 92. ScinoPharm Recent Development Table 93. JPT Company Information Table 94. JPT Business Overview Table 95. JPT Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. JPT Custom Peptide CDMO Services Product Portfolio Table 97. JPT Recent Development Table 98. CBL Company Information Table 99. CBL Business Overview Table 100. CBL Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CBL Custom Peptide CDMO Services Product Portfolio Table 102. CBL Recent Development Table 103. Piramal Pharma Company Information Table 104. Piramal Pharma Business Overview Table 105. Piramal Pharma Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Piramal Pharma Custom Peptide CDMO Services Product Portfolio Table 107. Piramal Pharma Recent Development Table 108. CPC Scientific Company Information Table 109. CPC Scientific Business Overview Table 110. CPC Scientific Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. CPC Scientific Custom Peptide CDMO Services Product Portfolio Table 112. CPC Scientific Recent Development Table 113. Creative Peptides Company Information Table 114. Creative Peptides Business Overview Table 115. Creative Peptides Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Creative Peptides Custom Peptide CDMO Services Product Portfolio Table 117. Creative Peptides Recent Development Table 118. Chinese Peptide Company Company Information Table 119. Chinese Peptide Company Business Overview Table 120. Chinese Peptide Company Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio Table 122. Chinese Peptide Company Recent Development Table 123. ChengDu ShengNuo Biotec Company Information Table 124. ChengDu ShengNuo Biotec Business Overview Table 125. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio Table 127. ChengDu ShengNuo Biotec Recent Development Table 128. AppTec Co., Ltd. Company Information Table 129. AppTec Co., Ltd. Business Overview Table 130. AppTec Co., Ltd. Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio Table 132. AppTec Co., Ltd. Recent Development Table 133. GL Biochem Company Information Table 134. GL Biochem Business Overview Table 135. GL Biochem Custom Peptide CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. GL Biochem Custom Peptide CDMO Services Product Portfolio Table 137. GL Biochem Recent Development Table 138. North America Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Custom Peptide CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Custom Peptide CDMO Services Market Share by Country (2021-2026) Table 141. North America Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Custom Peptide CDMO Services Market Share Forecast by Country (2027-2032) Table 143. Europe Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Custom Peptide CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Custom Peptide CDMO Services Market Share by Country (2021-2026) Table 146. Europe Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Custom Peptide CDMO Services Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Custom Peptide CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Custom Peptide CDMO Services Market Share by Country (2021-2026) Table 151. Asia-Pacific Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Custom Peptide CDMO Services Market Share Forecast by Country (2027-2032) Table 153. Latin America Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Custom Peptide CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Custom Peptide CDMO Services Market Share by Country (2021-2026) Table 156. Latin America Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Custom Peptide CDMO Services Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Custom Peptide CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Custom Peptide CDMO Services Market Share by Country (2021-2026) Table 161. Middle East & Africa Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Custom Peptide CDMO Services Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Custom Peptide CDMO Services Product Image Figure 3. Global Custom Peptide CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Custom Peptide CDMO Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Custom Peptide CDMO Services Market Share by Region: 2025 VS 2032 Figure 6. Global Custom Peptide CDMO Services Market Share by Region (2021-2032) Figure 7. North America Custom Peptide CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Custom Peptide CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Custom Peptide CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Custom Peptide CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Custom Peptide CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. GMP Services Image Figure 13. Global GMP Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-GMP Services Image Figure 15. Global Non-GMP Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Custom Peptide CDMO Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Custom Peptide CDMO Services Market Share by Type 2025 VS 2032 Figure 18. North America Custom Peptide CDMO Services Market Size Share by Type (2021-2032) Figure 19. Europe Custom Peptide CDMO Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Custom Peptide CDMO Services Market Size Share by Type (2021-2032) Figure 21. Latin America Custom Peptide CDMO Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Custom Peptide CDMO Services Market Size Share by Type (2021-2032) Figure 23. Commercial Image Figure 24. Global Commercial Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Custom Peptide CDMO Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Custom Peptide CDMO Services Market Share by Application 2025 VS 2032 Figure 31. North America Custom Peptide CDMO Services Market Size Share by Application (2021-2032) Figure 32. Europe Custom Peptide CDMO Services Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Custom Peptide CDMO Services Market Size Share by Application (2021-2032) Figure 34. Latin America Custom Peptide CDMO Services Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Custom Peptide CDMO Services Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Custom Peptide CDMO Services Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Custom Peptide CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Custom Peptide CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Custom Peptide CDMO Services Market Share by Country (2021-2032) Figure 41. Europe Custom Peptide CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Custom Peptide CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Custom Peptide CDMO Services Market Share by Country (2021-2032) Figure 44. Asia-Pacific Custom Peptide CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Custom Peptide CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Custom Peptide CDMO Services Market Share by Country (2021-2032) Figure 47. Latin America Custom Peptide CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Custom Peptide CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Custom Peptide CDMO Services Market Share by Country (2021-2032) Figure 50. Middle East & Africa Custom Peptide CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Custom Peptide CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Custom Peptide CDMO Services Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • GMP Services
  • Non-GMP Services
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • Bachem
  • CordenPharma
  • PolyPeptide
  • AmbioPharm
  • Genscript
  • Thermo Fisher
  • USV Peptides
  • Bio Basic
  • ScinoPharm
  • JPT
  • CBL
  • Piramal Pharma
  • CPC Scientific
  • Creative Peptides
  • Chinese Peptide Company
  • ChengDu ShengNuo Biotec
  • AppTec Co., Ltd.
  • GL Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Custom Peptide CDMO Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Custom Peptide CDMO Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Custom Peptide CDMO Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Custom Peptide CDMO Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Custom Peptide CDMO Services Market Size (2021-2032)
  8. 1.5.1 North America Custom Peptide CDMO Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Custom Peptide CDMO Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Custom Peptide CDMO Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Custom Peptide CDMO Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Custom Peptide CDMO Services Market Size Growth Rate (2021-2032)
2 Custom Peptide CDMO Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 GMP Services
  3. 2.1.2 Non-GMP Services
  4. 2.2 Global Custom Peptide CDMO Services Market Size by Type
  5. 2.2.1 Global Custom Peptide CDMO Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Custom Peptide CDMO Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Custom Peptide CDMO Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Custom Peptide CDMO Services Market Size by Regions
  9. 2.3.1 North America Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Type (2021-2026)
3 Custom Peptide CDMO Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Commercial
  3. 3.1.2 Scientific Research
  4. 3.1.3 Other
  5. 3.2 Global Custom Peptide CDMO Services Market Size by Application
  6. 3.2.1 Global Custom Peptide CDMO Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Custom Peptide CDMO Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Custom Peptide CDMO Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Custom Peptide CDMO Services Market Size by Regions
  10. 3.3.1 North America Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Custom Peptide CDMO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Custom Peptide CDMO Services Industry Trends
  2. 4.2 Custom Peptide CDMO Services Industry Drivers
  3. 4.3 Custom Peptide CDMO Services Industry Opportunities and Challenges
  4. 4.4 Custom Peptide CDMO Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Custom Peptide CDMO Services Revenue (2021-2026)
  2. 5.2 Global Custom Peptide CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Custom Peptide CDMO Services Key Company Headquarters & Area Served
  4. 5.4 Global Custom Peptide CDMO Services Company, Product Type & Application
  5. 5.5 Global Custom Peptide CDMO Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Custom Peptide CDMO Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Custom Peptide CDMO Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Custom Peptide CDMO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Bachem
  2. 6.1.1 Bachem Company Information
  3. 6.1.2 Bachem Business Overview
  4. 6.1.3 Bachem Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Bachem Custom Peptide CDMO Services Product Portfolio
  6. 6.1.5 Bachem Recent Developments
  7. 6.2 CordenPharma
  8. 6.2.1 CordenPharma Company Information
  9. 6.2.2 CordenPharma Business Overview
  10. 6.2.3 CordenPharma Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CordenPharma Custom Peptide CDMO Services Product Portfolio
  12. 6.2.5 CordenPharma Recent Developments
  13. 6.3 PolyPeptide
  14. 6.3.1 PolyPeptide Company Information
  15. 6.3.2 PolyPeptide Business Overview
  16. 6.3.3 PolyPeptide Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 PolyPeptide Custom Peptide CDMO Services Product Portfolio
  18. 6.3.5 PolyPeptide Recent Developments
  19. 6.4 AmbioPharm
  20. 6.4.1 AmbioPharm Company Information
  21. 6.4.2 AmbioPharm Business Overview
  22. 6.4.3 AmbioPharm Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AmbioPharm Custom Peptide CDMO Services Product Portfolio
  24. 6.4.5 AmbioPharm Recent Developments
  25. 6.5 Genscript
  26. 6.5.1 Genscript Company Information
  27. 6.5.2 Genscript Business Overview
  28. 6.5.3 Genscript Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Genscript Custom Peptide CDMO Services Product Portfolio
  30. 6.5.5 Genscript Recent Developments
  31. 6.6 Thermo Fisher
  32. 6.6.1 Thermo Fisher Company Information
  33. 6.6.2 Thermo Fisher Business Overview
  34. 6.6.3 Thermo Fisher Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Thermo Fisher Custom Peptide CDMO Services Product Portfolio
  36. 6.6.5 Thermo Fisher Recent Developments
  37. 6.7 USV Peptides
  38. 6.7.1 USV Peptides Company Information
  39. 6.7.2 USV Peptides Business Overview
  40. 6.7.3 USV Peptides Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 USV Peptides Custom Peptide CDMO Services Product Portfolio
  42. 6.7.5 USV Peptides Recent Developments
  43. 6.8 Bio Basic
  44. 6.8.1 Bio Basic Company Information
  45. 6.8.2 Bio Basic Business Overview
  46. 6.8.3 Bio Basic Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bio Basic Custom Peptide CDMO Services Product Portfolio
  48. 6.8.5 Bio Basic Recent Developments
  49. 6.9 ScinoPharm
  50. 6.9.1 ScinoPharm Company Information
  51. 6.9.2 ScinoPharm Business Overview
  52. 6.9.3 ScinoPharm Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ScinoPharm Custom Peptide CDMO Services Product Portfolio
  54. 6.9.5 ScinoPharm Recent Developments
  55. 6.10 JPT
  56. 6.10.1 JPT Company Information
  57. 6.10.2 JPT Business Overview
  58. 6.10.3 JPT Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 JPT Custom Peptide CDMO Services Product Portfolio
  60. 6.10.5 JPT Recent Developments
  61. 6.11 CBL
  62. 6.11.1 CBL Company Information
  63. 6.11.2 CBL Business Overview
  64. 6.11.3 CBL Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CBL Custom Peptide CDMO Services Product Portfolio
  66. 6.11.5 CBL Recent Developments
  67. 6.12 Piramal Pharma
  68. 6.12.1 Piramal Pharma Company Information
  69. 6.12.2 Piramal Pharma Business Overview
  70. 6.12.3 Piramal Pharma Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Piramal Pharma Custom Peptide CDMO Services Product Portfolio
  72. 6.12.5 Piramal Pharma Recent Developments
  73. 6.13 CPC Scientific
  74. 6.13.1 CPC Scientific Company Information
  75. 6.13.2 CPC Scientific Business Overview
  76. 6.13.3 CPC Scientific Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 CPC Scientific Custom Peptide CDMO Services Product Portfolio
  78. 6.13.5 CPC Scientific Recent Developments
  79. 6.14 Creative Peptides
  80. 6.14.1 Creative Peptides Company Information
  81. 6.14.2 Creative Peptides Business Overview
  82. 6.14.3 Creative Peptides Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Creative Peptides Custom Peptide CDMO Services Product Portfolio
  84. 6.14.5 Creative Peptides Recent Developments
  85. 6.15 Chinese Peptide Company
  86. 6.15.1 Chinese Peptide Company Company Information
  87. 6.15.2 Chinese Peptide Company Business Overview
  88. 6.15.3 Chinese Peptide Company Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio
  90. 6.15.5 Chinese Peptide Company Recent Developments
  91. 6.16 ChengDu ShengNuo Biotec
  92. 6.16.1 ChengDu ShengNuo Biotec Company Information
  93. 6.16.2 ChengDu ShengNuo Biotec Business Overview
  94. 6.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio
  96. 6.16.5 ChengDu ShengNuo Biotec Recent Developments
  97. 6.17 AppTec Co., Ltd.
  98. 6.17.1 AppTec Co., Ltd. Company Information
  99. 6.17.2 AppTec Co., Ltd. Business Overview
  100. 6.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio
  102. 6.17.5 AppTec Co., Ltd. Recent Developments
  103. 6.18 GL Biochem
  104. 6.18.1 GL Biochem Company Information
  105. 6.18.2 GL Biochem Business Overview
  106. 6.18.3 GL Biochem Custom Peptide CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 GL Biochem Custom Peptide CDMO Services Product Portfolio
  108. 6.18.5 GL Biochem Recent Developments
7 North America
  1. 7.1 North America Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Custom Peptide CDMO Services Market Size by Country (2021-2026)
  3. 7.3 North America Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Custom Peptide CDMO Services Market Size by Country (2021-2026)
  3. 8.3 Europe Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Custom Peptide CDMO Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Custom Peptide CDMO Services Market Size by Country (2021-2026)
  3. 10.3 South America Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Custom Peptide CDMO Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Custom Peptide CDMO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst